Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca kick-starts new COVID variant-busting vaccine test
Fierce Biotech
Mon, 06/28/21 - 10:55 am
Tags:
AstraZeneca, COVID-19, vaccines, AZD2816, COVID-19 variants
AZ starts phase 2/3 trial of new-variant COVID-19 vaccine
Pharmaforum
Sun, 06/27/21 - 10:52 pm
Tags:
AstraZeneca, clinical trials, vaccines, COVID-19
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes
Fierce Pharma
Fri, 06/25/21 - 12:16 pm
Tags:
AstraZeneca, Bydureon, diabetes, pediatric, type 2 diabetes, clinical trials
Pfizer and AZ Prove Their COVID-19 Vaccines Can Keep Up with Delta and Kappa Variants
BioSpace
Thu, 06/24/21 - 11:39 pm
Tags:
Pfizer, AstraZeneca, COVID-19, COVID-19 variants, vaccines
Jury awards former AstraZeneca sales manager $2.4M in whistleblower retaliation case
Fierce Pharma
Wed, 06/23/21 - 11:08 am
Tags:
AstraZeneca, whistleblowers, retaliation claims, False Claims Act, off-label
Farxiga faces first heart failure rival as EU OKs Boehringer/Lilly’s Jardiance
Pharmaforum
Wed, 06/23/21 - 10:59 am
Tags:
AstraZeneca, Farxiga, heart failure, Boehringer Ingelheim, Eli Lilly, Jardiance
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
Motley Fool
Wed, 06/23/21 - 10:40 am
Tags:
Pfizer, Moderna Therapeutics, AstraZeneca, CureVac, vaccines, COVID-19
AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost—and looks to add mRNA to the menu
Fierce Pharma
Mon, 06/21/21 - 10:05 pm
Tags:
SK Bioscience, AstraZeneca, Novavax, vaccines, drug manufacturing, COVID-19
AstraZeneca scores win in Europe's COVID-19 vaccine lawsuit, saying it can easily beat court supply mandate
Fierce Pharma
Sun, 06/20/21 - 10:19 pm
Tags:
AstraZeneca, COVID-19, vaccines, Europe
AstraZeneca and the EU both claim victory in court battle over slow vaccine deliveries
Biopharma Reporter
Fri, 06/18/21 - 10:12 am
Tags:
Europe, AstraZeneca, vaccines, COVID-19
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
Tags:
FDA, drug approvals, Argenx, Novartis, AstraZeneca, Astellas, UCB Pharma, Ascendis Pharma, ChemoCentryx, Axsome Therapeutics
AstraZeneca's Covid-19 antibody cocktail misses the mark in preventing symptoms post-exposure
Endpoints
Tue, 06/15/21 - 10:45 am
Tags:
AstraZeneca, monoclonal antibodies, AZD7442, COVID-19, clinical trials
Pfizer, AstraZeneca vaccines effective against delta variant, studies suggest
Beckers Hospital Review
Tue, 06/15/21 - 10:33 am
Tags:
Pfizer, AstraZeneca, COVID-19, vaccines, Delta COVID-19 variant
EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List
BioSpace
Mon, 06/14/21 - 11:47 pm
Tags:
AstraZeneca, COVID-19, vaccines, Europe, EMA, plasma leaks
In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment
Endpoints
Mon, 06/14/21 - 10:29 am
Tags:
AstraZeneca, JNJ, AbbVie, clinical trials, CLL, Gazyva, Imbruvica, Venclexta
Study links AstraZeneca COVID-19 shot to bleeding disorder ITP
Pharmaforum
Thu, 06/10/21 - 11:00 am
Tags:
AstraZeneca, vaccines, ITP, COVID-19
AstraZeneca takes PARP battle to court, seeking a larger claim to GSK's key cancer med Zejula: report
Fierce Pharma
Mon, 06/7/21 - 08:45 pm
Tags:
GSK, Tesaro, AstraZeneca, legal, Zejula, Lynparza
AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO
BioSpace
Mon, 06/7/21 - 08:41 pm
Tags:
AstraZeneca, ASCO 2021, breast cancer, CLL, Lynparza, Calquence
Alexion, AstraZeneca executives switch roles amid $39B buyout
BioPharma Dive
Sun, 06/6/21 - 10:33 pm
Tags:
AstraZeneca, Alexion, M&A
#ASCO21: AstraZeneca's PD-1 Imfinzi tacks on 5-year survival data in NSCLC, which it's calling 'unprecedented'
Endpoints
Fri, 06/4/21 - 10:48 am
Tags:
ASCO 2021, AstraZeneca, non-small cell lung cancer, Imfinzi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.